CERo Therapeutics Holdings, Inc. Profile Avatar - Palmy Investing

CERo Therapeutics Holdings, Inc.

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell an…

Biotechnology
US, South San Francisco [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

CERo Therapeutics Holdings, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
0.0 IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
YoY Trends
  • No trends presentable at the moment.

Spending By Type

Awards
Obligations
Contracts IDV Contracts Grants Loans Direct Other

CERo Therapeutics Holdings, Inc. can't present spending by time.

End of CERO's Analysis
CIK: 1870404 CUSIP: - ISIN: US71902K1051 LEI: - UEI: -
Secondary Listings
CERO has no secondary listings inside our databases.